American Conference Institute will be holding its 16th Advanced Forum on Life Sciences Collaborative Agreements and M&A in New York on February 27th and 28th.
The agenda includes the following presentations:
- What the America Invents Act means for deal makers and business development strategies
- Identifying IP red flags that impact the value and success of a life sciences transaction
- Deciphering alternative business models to select the best deal structure in a time of changing industry dynamics
- Preparing your IP for M&A or product license: what savvy buyers look for
- Partner selection for facilitating product development and maximizing commercial returns
- Opening doors to new markets and products with strategic alliances
- Bayh-Dole after Stanford: revisiting research agreements with academic institutions
- Exploring perspectives of innovative small companies on the industry's prospects for 2012 and beyond
- Bridging gaps between buyers and sellers: finding the right valuation and closing the deal
- Overcoming negotiating hurdles in developing profitable public-private deals
- "No regrets" drafting: terms to include at the outset that facilitate product commercialization and profitable cooperation between partners
- Building strategic end value into your agreement
In addition, ACI is offering a post-conference Life Sciences M&A/Strategic Alliances Due Diligence Master Class on February 29th.
For more information or to register, please visit the conference website. To receive a $200 discount on registration fees, use discount code OBB 200.